News

press-release-clinical-trial-myxpression
mYXpression begins a clinical trial to demonstrate the efficacy of RITI® rhumato
mYXpression begins a clinical trial to demonstrate the efficacy of RITI® rhumato, a test to help prescribe...
Image-articles-blog-EN
mYXpression receives CE mark clearance for its software Pear 2.0, a key milestone to launch RITI®, a test to assist rheumatologists in their prescription of biologics.
This regulatory approval is the achievement of a 2-year work by all mYXpression employees and partners....
Search
Categories